På denne side bringer DANSK BIOTEK nyheder fra medlemmerne, som på denne måde får mulighed for at blive ekstra eksponeret.

Vi modtager derfor gerne pressemeddelelser og andre nyheder. Send dem til Dorte Dannemann, hjælp af denne formular.

06 Nov 2017

Orphazyme publishes offering circular and the indicative offer price range for its IPO

Orphazyme, a Danish biotech company with a late stage orphan drug pipeline, today published an offering circular and the indicative price range in connection with its intended initial public offering (“IPO” or the “Offering”) and subsequent admission to trading and official listing of its shares on Nasdaq Copenhagen.

The indicative offer price range is DKK 64 to DKK 80 per share of nominal value DKK 1 each, and commitments to subscribe for a number of shares in the Offering, subject to certain conditions, have already been expressed by SEB, Vækstfonden, BankInvest on behalf of certain clients, Handelsbanken and Spar Nord – corresponding to DKK 230 million.

  • Orphazyme offering circular announcement

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or 28895854

Copyright 2017 Danskbiotek. All rights reserved.